(2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide,
afatinib,
afatinib dimaleate,
afatinib maleate,
BIBW 2992,
BIBW 2992 MA2,
BIBW 2992MA2,
BIBW-2992,
BIBW-2992-MA2,
BIBW-2992MA2,
BIBW2992,
BIBW2992 MA2,
Gilotrif,
AFATINIB DIMALEATE,
850140-73-7,
Afatinib (diMaleate),
Gilotrif,
BIBW 2992MA2,
UNII-V1T5K7RZ0B,
Afatinib (BIBW2992) Dimaleate,
Afatinib dimaleate [USAN],
V1T5K7RZ0B,
CHEBI:76003,
Afatinib dimaleate (USAN),
Giotrif,
Afatinib maleate,
Gilotrif (TN),
Giotrif (TN),
Afatinib maleate (JAN),
(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate),
afatinib-bibw2992-dimaleate,
BIBW2992 MA2,
CHEMBL2105712,
USNRYVNRPYXCSP-JUGPPOIOSA-N,
(Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,
AOB87350,
HY-10261A,
AKOS025401819,
ACN-043929,
CS-1329,
AC-26080,
QC-11139,
SC-87788,
D09733,
(2E)-N-(4-[(3-chloro-4-fluorophenyl)amino]-7-{[(3S,
(2E)-N-(4-[(3-chloro-4-fluorophenyl)amino]-7-{[(3S)-tetrahydrofuran-3-yl]oxy}quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,
(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide di[(2Z)-but-2-enedioate],
(E)-4-Dimethylamino-But-2-Enoic Acid-(4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetra-Hydrofuran-3-Yloxy)-Quinazolin-6Yl)-Amide Dimaleate,
2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2),
Afatinib,
Tomtovok,
Tovok,
BIBW2992-MA2,
CS-O-12080,
CID15606394,
Afatinib dimaleate, 99% - 10MG 10mg,
CID 15606394,
3098S,
A3145,
BIBW2992 DiMaleate,Afatinib (BIBW2992) Dimaleate,
850140-72-6,